-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JTTGDMzrcyaKgbjWvKMfvxWKisSuVe+Ap2YjpO1HnmKds0uqOJI/U6y0mwT9XhVR tij5ZX3nfw19r8gQeAQ+Fg== 0001047469-04-031771.txt : 20041021 0001047469-04-031771.hdr.sgml : 20041021 20041021133411 ACCESSION NUMBER: 0001047469-04-031771 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20041021 DATE AS OF CHANGE: 20041021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-108320 FILM NUMBER: 041089307 BUSINESS ADDRESS: STREET 1: 145 BRANDYWINE PKWY CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 145 BRANDYWINE PARKWAY CITY: WEST CHESTER STATE: PA ZIP: 19380 424B3 1 a2145296z424b3.htm 424B3
Prospectus Supplement No. 7
to Prospectus dated December 4, 2003
  Filed pursuant to Rule 424(b)(3)
File No. 333-108320

CEPHALON, INC.

$375,000,000 Zero Coupon Convertible Subordinated Notes Due June 15, 2033
First Putable June 15, 2008

$375,000,000 Zero Coupon Convertible Subordinated Notes due June 15, 2033
First Putable June 15, 2010

12,939,674 Shares of Common Stock


        This document supplements information contained in that certain prospectus of Cephalon, Inc., dated December 4, 2003, as amended and supplemented from time to time, relating to the potential resale from time to time of $375,000,000 zero coupon convertible subordinated notes due June 15, 2033, first putable June 15, 2008 (the "2008 notes"), $375,000,000 zero coupon convertible subordinated notes due June 15, 2033, first putable June 15, 2010 (the "2010 notes", and together with the 2008 notes, the "notes"), and 12,939,674 shares of common stock issuable upon conversion of the notes, and the potential resale from time to time of these securities by the selling securityholders identified in the prospectus and any prospectus supplements. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any amendments or supplements thereto.

        The following table supplements, or amends, as noted, the information contained in the table set forth in the prospectus under the caption "Selling Securityholders." This table sets forth the beneficial ownership by the selling securityholders of (i) the 2008 and 2010 notes, respectively, and (ii) shares of our common stock, including common stock issuable upon conversion of the notes, and the maximum principal amount of the notes and number of shares of common stock that may be offered by the selling securityholders under the prospectus. The percentages of all shares of common stock beneficially owned before and after the resale of the notes and the common stock issuable upon conversion of the notes are based on 57,686,997 shares of common stock outstanding as of October 20, 2004. The Securities and Exchange Commission has defined "beneficial" ownership of a security to mean the possession, directly or indirectly, of voting power and/or investment power. A stockholder is also deemed to be, as of any date, the beneficial owner of all securities that the stockholder has the right to acquire within 60 days after that date through (a) the exercise of any option, warrant, or right, (b) the conversion of a security, (c) the power to revoke a trust, discretionary, discretionary account or similar arrangement, or (d) the automatic termination of a trust, discretionary account or similar arrangement. Shares of common stock may also be sold by donees, pledgees or other transferees or successors in



interest of the selling securityholders. The following table is based upon information furnished to us by the selling securityholders.

 
   
   
   
   
  Beneficial Ownership After Resale of Notes or Common Stock
 
  Number of Shares of Common Stock Beneficially Owned(1)
   
   
   
 
  Principal
Amount of
2008 Notes
Beneficially
Owned

  Principal
Amount of
2010 Notes
Beneficially
Owned

  Maximum
Number of
Shares of Common
Stock That
May Be Sold(2)

Name of Selling Securityholder

  Principal
Amount of
Notes(3)

  Percent
  Number of
Shares of
Common
Stock(3)

  Percent
The following information amends the information set forth in the prospectus originally filed or as previously amended or supplemented:                                    
  Goldman Sachs & Company(4)   185,102   $ 3,428,000   $ 5,857,000   161,276       185,102   *
  Marathon Global Convertible Master Fund, Ltd.(5)     $ 30,475,000   $ 21,750,000   897,139        
  S.A.C. Arbitrage Fund, LLC(6)   171,996   $ 5,500,000       92,436       171,996   *

*
Less than 1%.

(1)
Assumes no conversion of the notes, which conversion may occur upon the satisfaction of several conditions described in the section of the prospectus entitled "Description of the Notes—Conversion of the Notes".

(2)
Represents the maximum number of shares of common stock issuable upon conversion of the notes based upon a conversion factor of .0168067 multiplied by the principal amount of the 2008 notes beneficially held, and a conversion factor of .0176991 multiplied by the principal amount of the 2010 notes beneficially held. These conversion factors are subject to adjustments as described in the section of the prospectus entitled "Description of the Notes—Conversion of the Notes—Conversion Price Adjustments." As a result, the maximum number of shares of common stock issuable upon conversion of the notes will correspondingly decrease or increase to the extent that the conversion factors for the notes increase or decrease.

(3)
Assumes that either all of the principal amount of notes offered hereby or all of the shares of common stock issued upon conversion of such notes are sold by the selling securityholder.

(4)
The information set forth for this securityholder is as of October 12, 2004 and will be updated as required.

(5)
The information set forth for this securityholder is as of September 15, 2004 and will be updated as required.

(6)
The information set forth for this securityholder is as of October 4, 2004 and will be updated as required.

        Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is October 21, 2004.

2



-----END PRIVACY-ENHANCED MESSAGE-----